Insmed
INSM
#847
Rank
A$40.80 B
Marketcap
A$189.03
Share price
-6.02%
Change (1 day)
73.16%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -A$1.83 Billion

According to Insmed's latest financial reports the company's current earnings are A$0.60 Billion. a decrease over its 2024 earnings that were of -A$1.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -A$1.67 Billion43.91%
2024 -A$1.17 Billion23.71%
2023 -A$0.94 Billion45.77%
2022 -A$0.65 Billion15.83%
2021 -A$0.56 Billion50.19%
2020 -A$0.37 Billion16.4%
2019 -A$0.32 Billion-23.9%
2018 -A$0.42 Billion59.35%
2017 -A$0.27 Billion8.52%
2016 -A$0.25 Billion47.25%
2015 -A$0.17 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$76.75 Million35.14%
2012 -A$56.8 Million-31.92%
2011 -A$83.43 Million854.92%
2010 -A$8.74 Million-105.22%
2009 A$0.16 B-905.06%
2008 -A$20.78 Million-27.31%
2007 -A$28.59 Million-62.41%
2006 -A$76.04 Million98.19%
2005 -A$38.37 Million0.03%
2004 -A$38.36 Million159.07%
2003 -A$14.81 Million-69.31%
2002 -A$48.24 Million
2000 -A$43.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.86 B-1,469.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$13.70 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.51 B-489.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.36 Billion-78.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$32.51 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.16 M-100.37%๐Ÿ‡บ๐Ÿ‡ธ USA